Work

An Interim Analysis of Efficacy and Safety Data in Black and Hispanic Patients With Multiple Sclerosis Receiving Ocrelizumab Treatment in the CHIMES Trial (S31.006)

Year: 2023

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000203125

Authors: Evanthia Bernitsas, Anthony Reder, Angel Chinea, Craig Herrman, Barbara O’Brien, Richard Sater, Lilyana Amezcua, Mitzi Williams, Gregory Wu, Timothy Vartanian, Jinglan Pei, Juan Acosta, Nancy Monson

Institutions: Wayne State University, University of Chicago, Baptist Memorial Hospital, Cone Health, University of Southern California, Washington University in St. Louis, Cornell University, Weill Cornell Medicine, Genentech, The University of Texas Southwestern Medical Center

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

OpenAlex ID: W4367302941

FWCI:

Cites:

Cited by:

Related to: 10